INTRODUCTION
The Wnt family of proteins are conserved from coelenterate to human and regulate cell proliferation, fate specification, polarity, and migration (Cadigan and Nusse, 1997; Lee et al., 2006) . In the canonical Wnt pathway (Huelsken and Birchmeier, 2001 ; Wodarz and Nusse, 1998) , Wnt binding to Frizzled receptors and the low-density lipoprotein receptor-related protein 5 or 6 (LRP5/6) in vertebrates (Mao et al., 2001b; Pinson et al., 2000; Tamai et al., 2000) stabilizes b-catenin and thereby activates transcription of downstream target genes via lymphoid enhancer binding factor-1 (Lef-1) and T cell factors (Tcf1, 3, 4). The amplitude of signaling is fine tuned in part via negative feedback mechanisms that include the secreted molecule Dickkopf 1 (Dkk1) (Glinka et al., 1998) , itself a direct transcriptional target of canonical Wnt signaling (Chamorro et al., 2005; Niida et al., 2004) . Dkk1 antagonizes the pathway by interfering with LRP5/6 and Wnt interactions (Bafico et al., 2001; Mao et al., 2001a; Semenov et al., 2001) .
Wnts also signal through b-catenin-independent (noncanonical) mechanisms to regulate morphogenesis during vertebrate development (Veeman et al., 2003) . Most notably, noncanonical Wnt signaling has been implicated in convergence and extension of the body axis during embryogenesis in Xenopus Wallingford et al., 2000) , zebrafish (Heisenberg et al., 2000) , and mice (Kibar et al., 2001; Wang et al., 2006) . In addition, noncanonical Wnt signaling was shown to regulate both polarized extension and planar cell polarity (PCP) in the mouse cochlea (Curtin et al., 2003; Kibar et al., 2001; Montcouquiol et al., 2003; Wang et al., 2005) . Thus, noncanonical Wnt signaling directs cell polarity and cell movement in a variety of vertebrate species.
The intracellular cascade responsible for noncanonical Wnt signaling in vertebrates is not well understood. Overexpression of Xenopus Wnt5a, rat Frizzled 2, or a Xenopus Dishevelled (Dvl) construct lacking the DIX domain (XDshDDIX) in Xenopus or zebrafish embryos stimulated calcium flux and PKC activity by activating phosphatidylinositol signaling sensitive to pertussis toxin (Kuhl et al., 2000; Sheldahl et al., 2003; Slusarski et al., 1997) . However, the role of classic PKC is not known, although PKCd, a novel PKC isoform, was shown to regulate Xenopus convergent extension in response to Frizzled signaling (Kinoshita et al., 2003) . Neither is it known whether a similar signaling cascade operates in mammalian cells. In addition, certain Wnts or Frizzled molecules were found to activate the Rho family of small GTPases in HEK293T cells and Xenopus embryos (Habas et al., 2003; Habas et al., 2001) . The pathway was implicated in convergent extension in Xenopus embryos (Choi and Han, 2002; Habas et al., 2001 Habas et al., , 2003 Penzo-Mendez et al., 2003) , but a similar role has not been demonstrated in mammals.
The importance of canonical Wnt signaling in bone is supported by genetic evidence from mammals. In humans, loss-or gain-of-function mutations in LRP5 were linked with the osteoporosis-pseudoglioma syndrome (Gong et al., 2001 ) and a high-bone-density syndrome (Boyden et al., 2002; Little et al., 2002) , respectively. Mice lacking LRP5 (LRP5 À/À ) (Kato et al., 2002) or Wnt10b (Wnt10b À/À ) (Bennett et al., 2005 ) exhibited a postnatal low-bone-mass phenotype. Conversely, mice lacking the Wnt antagonist secreted Frizzled-related protein 1 (sFRP1
) developed more bone postnatally (Bodine et al., 2004) . Moreover, genetic deletion of b-catenin from early osteoprogenitors resulted in a lack of mature osteoblasts in the mouse embryo (Day et al., 2005; Hill et al., 2005; Hu et al., 2005; Rodda and McMahon, 2006) , whereas forced activation of b-catenin greatly enhanced osteogenesis (Rodda and McMahon, 2006) . Specifically, b-catenin was shown to be required both prior to Osterix (Osx) expression and for the progression of Osx-positive cells to mature osteoblasts (Rodda and McMahon, 2006) . Finally, b-catenin signaling in more mature osteoblasts was found to indirectly control bone mass by regulating osteoclast formation through the control of Osteoprotegerin expression (Glass et al., 2005) .
A role for noncanonical Wnt signaling in bone has not been described. Here, we report a Wnt-Ga q/11 -PKCd noncanonical pathway that operates in mammalian osteoprogenitors to promote osteoblast development. We further demonstrate that Wnt7b likely promotes bone formation in the mouse in part via this mechanism.
RESULTS

Wnt3a Induces Osteoblastogenesis Coupled with PKC Activation in ST2 Cells
To investigate the molecular mechanism underlying Wnt signaling during osteoblast differentiation, we established a Wnt-responsive osteoblastogenesis system. The murine bone marrow-derived stromal cell line ST2 (Ogawa et al., 1988) , upon incubation with a conditioned medium containing Wnt3a (hereafter called Wnt3a medium), expressed a markedly higher alkaline phosphatase (AP) activity than cells cultured in a control conditioned medium (hereafter called L medium) ( Figure 1A ). Real-time PCR revealed that AP mRNA levels steadily increased during the first 3 days of Wnt3a treatment before reaching a plateau ( Figure 1C) . Similarly, expression of bone sialoprotein (Bsp) was activated within the first 24 hr and reached a plateau by 72 hr of Wnt3a treatment ( Figure 1C ). On the other hand, osteocalcin (OC), a marker for mature osteoblasts, was induced only after 96 hr of Wnt3a stimulation (Figure 1C) . Interestingly, Wnt3a did not stimulate Runx2 expression, but it significantly induced Osterix (Osx) after 96 hr ( Figure 1C ). Moreover, in the presence of ascorbic acid and b-glycerophosphate, Wnt3a induced the widespread formation of mineralized nodules ( Figure 1B) . Finally, purified recombinant Wnt3a dose dependently induced AP in ST2 cells in a serum-free medium (Figure 1D) . Thus, Wnt3a is sufficient to induce osteoblast differentiation in ST2 cells.
To identify downstream molecules responsible for Wntinduced osteoblastogenesis, a proteomics approach was taken to compare protein profiles in ST2 cells cultured in Wnt3a medium versus L medium. Meristoylated alaninerich C kinase substrate (MARCKS), a prototypic substrate for protein kinase C (PKC) (Blackshear, 1993) , was detected at an increased level after 24 hr of Wnt3a stimulation ( Figure 1E , arrows), a result confirmed by western analyses of total cell lysates ( Figure 1F ). As MARCKS is known to redistribute from the plasma membrane to the cytosol after phosphorylation (Arbuzova et al., 2002) , the cytosolic fractions of cells were therefore analyzed for the levels of phosphorylated MARCKS by using a phospho-specific antibody. These studies revealed that MARCKS phosphorylation was markedly enhanced after 1 hr of incubation in Wnt3a medium, and that upregulation was sustained for at least 24 hr ( Figure 1G ). In fact, when cells were stimulated with purified Wnt3a without serum, phospho-MARCKS was readily detectable at 10 min poststimulation, and levels steadily rose within the first hour ( Figure 1H ). Thus, Wnt3a robustly induces MARCKS phosphorylation in ST2 cells.
PKCd Mediates Wnt3a-Induced Osteoblastogenesis, Independent of b-Catenin Induction of MARCKS phosphorylation prompted us to examine the role of PKC in Wnt3a-induced osteoblastogenesis. The PKC family of serine and threonine protein kinases consists of at least 11 members, including the classic PKC isoforms (a, b1, b2, g) activated by diacylglycerol (DAG), phosphatidylserine, and Ca 2+ ; the novel PKC subfamily (d, 3, h, q) activated by DAG and phosphatidylserine; and the atypical PKC isoforms (l, i, z) activated only by phosphatidylserine (Newton, 1997) . Ro-31-8220, an inhibitor for all PKC isoforms, significantly impaired AP induction by Wnt3a (Figure 2A ). However, Gö 6976, an inhibitor specific for classic PKC, had no effect even at 10 mM (IC 50 2.3 nM for PKCa, 6.7 nM for PKCb) ( Figure 2A) . Similarly, the intracellular Ca 2+ chelator BAPTA/AM did not inhibit Wnt3a-induced AP expression ( Figure 2A ). In addition, a peptide inhibitor specific for atypical PKC (PKCz pseudosubstrate) also failed to inhibit Wnt3a-induced osteoblastogenesis (data not shown). In contrast, rottlerin, a selective inhibitor for PKCd and PKCq, significantly reduced AP induction in a dose-dependent manner (Figure 2A ), but a PKCq pseudosubstrate had no effect (data not shown). The inhibition of osteoblastogenesis by rottlerin was confirmed by real-time PCR of osteoblast markers ( Figure S1 ; see the Supplemental Data available with this article online). Similarly, rottlerin inhibited Wnt3a-induced AP activity in primary cultures of limb primordial cells, isolated from E13.5 mouse embryos and containing osteoprogenitors but no mature osteoblasts ( Figure 2B ). Moreover, rottlerin abolished Wnt3a-induced MARCKS phosphorylation in ST2 cells ( Figure 1H ). Thus, PKCd is required for Wnt3a-induced osteoblast differentiation and MARCKS phosphorylation.
To determine whether inhibition of PKC interfered with canonical Wnt signaling, we examined the potential effect of Ro-31-8220 or rottlerin on Wnt3a-induced transcriptional activation of a Lef1-luciferase reporter as well as b-catenin stabilization. Not only did Ro-31-8220 not impair Wnt3a-induced luciferase expression or b-catenin stabilization, it synergized with Wnt3a ( Figures 2C and  2D) . The fact that Ro-31-8220 also inhibits GSK3b, a known negative regulator of canonical Wnt signaling, may explain this observation. Similarly, rottlerin did not impair Wnt3a-induced b-catenin stabilization ( Figure 2D ). Thus, PKCd mediates Wnt-induced osteoblastogenesis independent of canonical Wnt signaling.
To corroborate the role of PKCd, we knocked down its expression with siRNA. Western analyses confirmed that PKCd siRNA reduced the protein level of PKCd by $66% ( Figure 3E ). Importantly, the knockdown decreased Wnt3a-induced AP induction by $50% ( Figure 3A) . Similarly, overexpression of a dominant-negative form of PKCd (PKCd-DC) by using a retroviral vector severely impaired Wnt3a-induced AP expression (data not shown). Moreover, when cultured in a mineralization medium, cells expressing PKCd-DC formed significantly fewer bone nodules than control cells expressing GFP (Figures 3G and 3H) . These results support the conclusion that PKCd activity is required in Wnt3a-induced osteoblast differentiation. G q -Activated Phosphatidylinositol Signaling, Independent of b-Catenin, Mediates Wnt3a-Induced Osteoblastogenesis We next set out to unravel the signaling cascade leading to PKCd activation in response to Wnt3a. PKCd is activated by DAG, which is, in turn, produced through hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by phospholipase C (PLC). Since the PLC-b isoenzymes are activated by both the G q subfamily of a subunits and the bg subunits of heterotrimeric G proteins (Morris and Malbon, 1999) , we examined whether G protein-linked phosphatidylinositol signaling was responsible for Wnt3a-induced PKCd activation and subsequent osteoblastogenesis. Pertussis toxin, which catalyzes ADP ribosylation of the G i family of the a subunits, thus uncoupling them from their activating receptors, is known to inhibit PLC-b activation by the bg subunits (Morris and Malbon, 1999) . The toxin, however, did not inhibit Wnt3a-induced osteoblast differentiation in ST2 cells (data not shown). We therefore focused subsequent studies on G q signaling.
To examine the role of G q signaling in Wnt-induced osteoblastogenesis, we took advantage of a dominant-negative reagent, G q I, which is a COOH-terminal peptide (aa 305-359) of Ga q previously shown to partially inhibit G q signaling (Akhter et al., 1998) . G q I expression significantly reduced Wnt3a-induced AP expression ( Figure 3B ), as well as bone nodule formation ( Figures 3I and 3J ). Thus, G q signaling likely mediates Wnt3a-induced osteoblastogenesis.
To confirm the role of the G q subfamily of a subunits, we reduced the levels of Ga q and Ga 11 , two widely expressed members, with siRNA. A combination of siRNA oligonucleotides against Ga q or Ga 11 reduced their combined protein levels by $43%, as detected by an antibody recognizing both molecules ( Figure 3F ). Importantly, these oligonucleotides reduced Wnt3a-induced AP expression by >50% ( Figure 3C ). Similarly, single knockdowns of either Ga q or Ga 11 also partially inhibited AP induction (data not shown). Thus, both Ga q and Ga 11 are likely to mediate Wnt3a-induced osteoblast differentiation.
To further test the function of phosphatidylinositol signaling, we examined the effect of U73122, a PLC inhibitor, on Wnt3a-induced osteoblastogenesis. U73122 not only inhibited AP induction by $50% ( Figure 3D ), but it also reduced bone nodule formation ( Figures 3K and 3L ). Thus, PLC activity is important for Wnt-induced osteoblast differentiation.
Next, we examined whether inhibition of G q signaling or PLC activity affected Wnt3a-induced PKCd activation or b-catenin stabilization. Both U73122 ( Figure 3M ) and G q I ( Figure 3N ) markedly reduced phospho-MARCKS, without significantly altering b-catenin stabilization. These results indicate that Wnt3a activates a Ga q/11 / PLCb / PKCd pathway independent of b-catenin signaling to promote osteoblast differentiation. 
PKCd Activation by Wnt3a Requires Dvl, but Is Insensitive to Dkk1
We next examined whether PKCd activation involves the Dvl family of molecules. Immunostaining revealed that in unstimulated ST2 cells, both PKCd and Dvl-2 were present diffusely in the cytosol ( Figures 4E-4G ). However, within 30 min of Wnt3a stimulation, both molecules were translocated to the plasma membrane in a punctate pattern, although some signal remained in the perinuclear region ( Figures 4A and 4B ). Remarkably, PKCd and Dvl-2 colocalized at the plasma membrane ( Figure 4C ). Similar results were observed with Dvl-1 and Dvl-3 (Figures S2 and S3). Thus, Wnt3a signaling translocates PKCd and Dvl to common domains within the plasma membrane.
To determine the kinetics of membrane translocation for PKCd and Dvl-2, we used western analyses to quantify the levels of these proteins in the cytosol after Wnt3a stimulation. At 10 min poststimulation, both PKCd and Dvl-2 were markedly reduced in the cytosol ( Figure 4I , lane 2). At 30 min, the cytosolic content of PKCd or Dvl-2 was partially recovered but remained significantly lower than the prestimulation level ( Figure 4I , lane 3). Interestingly, at 60 min, both proteins were present in the cytosol at a higher than prestimulation level ( Figure 4I , lane 4). Consistent with activation of PKCd at the cell membrane, the levels of phospho-MARCKS in the cytosol steadily rose within the first hour of stimulation (Figures 1H and 4I) . Thus, concurrent with PKCd activation, Wnt3a signaling acutely and transiently translocates PKCd and Dvl-2 to the plasma membrane with similar kinetics.
We next examined whether Dvl signaling is required for PKCd activation. Since the DIX, PDZ, and DEP domains (A-D) AP expression in cells incubated for 48 hr in conditioned medium. In (A) and (C), cells transfected with siRNA were incubated in normal growth medium for 96 hr before being cultured in conditioned medium. In (B), cells were first infected with retrovirus before being incubated in conditioned medium. n = 3. (E and F) Western analyses for (E) PKCd and (F) Ga q /Ga 11 in whole-cell lysates of cells at 96 hr after siRNA transfection, with GAPDH siRNA as control. (G-L) Detection of bone nodules by alizarin red. In (G)-(J), cells were infected with retrovirus before being incubated in Wnt3a-mineralization medium. U73122 was used at 5 mM. (M and N) Western analyses for b-catenin and phospho-MARCKS in cytosolic fractions. Cells prestarved for 24 hr were cultured in serum-free medium for 1 hr with or without recombinant Wnt3a. In (N), cells were first infected with viruses, and then starved for 24 hr before Wnt3a stimulation. Western signals were normalized to a-tubulin.
were reported to preferentially mediate distinct Wnt pathways, we set out to evaluate whether overexpression of Dvl-2 variants lacking one of the three conserved domains (DDIX, DPDZ, and DDEP) (Habas et al., 2001 ) differentially affects Wnt3a-induced PKCd activation versus b-catenin stabilization. Cells expressing any of the Dvl-2 variants showed a marked reduction in MARCKS phosphorylation ( Figure 3N ). Similarly and unexpectedly, all three Dvl-2 variants also inhibited b-catenin accumulation ( Figure 3N ). These results support the conclusion that Dvl proteins are required for both PKCd activation and b-catenin stabilization in response to Wnt3a, and that all three conserved domains may participate in both pathways.
To determine whether the Wnt-PKCd pathway requires LRP5/6 signaling, we examined whether the membrane translocation of PKCd in response to Wnt3a is sensitive to Dkk1 inhibition. Here, cells infected with a retrovirus coexpressing Dkk1 and nuclear GFP were immunostained for endogenous PKCd, with or without Wnt3a stimulation. As in control cells ( Figure 4A ), Wnt3a induced characteristic translocation of PKCd from the cytosol ( Figure 4H ) to the plasma membrane ( Figure 4D ) in cells overexpressing Dkk1. Thus, Dkk1 does not inhibit Wnt3a-induced membrane translocation of PKCd.
We next examined whether Dkk1 inhibits Wnt3a-induced PKCd activation. To this end, cytosolic proteins from virally infected cells with or without Wnt3a stimulation were assayed for phospho-MARCKS by western analyses. As a control for the efficacy of the Dkk1 virus, b-catenin levels were also analyzed. In addition, the virally infected cells were transfected with the Lef1-luciferase reporter and were assayed for response to Wnt3a. As expected, in Dkk1-overexpressing cells, Wnt3a failed to either stabilize b-catenin ( Figure 4J ) or activate transcription of the reporter ( Figure 4K ). On the other hand, Wnt3a induced phosphorylation of MARCKS in these cells (I-J) Western analyses in cytosolic fractions. Cells were prestarved in serum-free medium for 24 hr before being stimulated with recombinant Wnt3a for (I) the indicated times or for (J) 1 hr. In (J), cells were first infected with retroviruses expressing either GFP or Dkk1 before starvation. Signal levels were normalized to a-tubulin. (K) The effect of Dkk1 on Lef1-luciferase activation by Wnt3a. n = 3. in a manner similar to that in the control cells ( Figure 4J ). Thus, in contrast to the canonical Wnt pathway, WntPKCd signaling does not appear to engage the LRP5/6 coreceptors.
Genetic Deletion of PKCd Results in a Reduction in Embryonic Bone Formation
To determine the role of PKCd in bone formation in vivo, we analyzed the skeleton of PKCd knockout mice (PKCd À/À ). The PKCd À/À animals are viable and fertile but were reported to exhibit hyperactivation of B cell proliferation and auto-immunity (Miyamoto et al., 2002) , as well as deficiency in stress-induced apoptosis of blood vessel smooth muscle cells (Leitges et al., 2001) . We reasoned that removal of PKCd might lead to quantitative defects more evident during early phases of bone formation, and we therefore focused our analyses on early embryos. At E15.5, the wild-type embryos showed obvious ossification in the maxilla, the mandible, the ribs, and the limbs ( Figure 5A ). In contrast, PKCd À/À littermates exhibited much less ossification ( Figure 5B ). In particular, the maxilla and the mandible of mutant embryos showed only minimal mineralization compared with wild-type littermates (Figure 5, compare [C] and [D] ). In limbs, bone collars of ossifying skeletal elements were notably shorter in the mutant embryo ( Figure 5E ). Accordingly, von Kossa staining on sections of long bones showed that bone collars were shortened in mutants at both E14.5 and E15.5 ( Figure 5F ). Indeed, the relative bone collar length normalized to the total skeletal element length was significantly reduced in the mutant ( Figure 5G ). Thus, removal of PKCd results in less bone in the early embryonic skeleton.
As bone collar formation in the embryo is coupled with cartilage development, we examined the status of chondrocyte maturation in PKCd À/À versus wild-type littermates. At E14.5, in mutant embryos, the hypertrophic zone expressing Cola1(X) was shortened; the domains expressing parathyroid hormone-related peptide-receptor (PTHrP-R) and Indian hedgehog (Ihh) were less well separated, and the terminal hypertrophic zone expressing matrix metalloproteinase 13 (MMP 13) was reduced (Figure 5H) . Thus, loss of PKCd delays chondrocyte maturation in long bones. We next examined whether progression of osteoblast differentiation was perturbed in PKCd À/À embryos. To this end, we took advantage of the fact that osteoblastogenesis in the perichondrium of long bones progresses linearly along the epiphysis to diaphysis axis. In particular, the onset of expression for later osteoblast markers is coupled with chondrocyte maturation, resulting in characteristic positioning of the leading edge in relation to the hypertrophic cartilage. Thus, we examined the expression of a panel of osteoblast markers in the perichondrium by in situ hybridization, and we evaluated whether their positioning against the Cola1(X)-expressing hypertrophic chondrocytes on adjacent sections was altered in PKCd À/À versus wild-type littermates at E15.5. In the wild-type embryo, the early markers AP ( Figure 5I , arrow), Cola1(I), and Runx2 (data not shown) were detected throughout much of the metaphyseal perichondrium. On the other hand, Osx and Bsp were activated in perichondrial cells immediately preceding the hypertrophic region, with their leading edges (orange, vertical lines) positioned at a characteristic distance from the first row of Cola1(X)-positive cells (purple, vertical line) ( Figure 5I ). In the PKCd À/À embryo, the expression patterns of AP ( Figure 5I ),
Cola1(I)
, and Runx2 (data not shown) were similar to those in the wild-type littermates. However, the leading edges of Osx and Bsp (green, vertical lines) were significantly closer to the boundary of the hypertrophic zone (purple, vertical line) ( Figure 5I ). Thus, removal of PKCd appears to delay the onset of Osx expression in the osteoblast lineage, which may, in turn, impede subsequent differentiation.
To confirm that loss of PKCd results in intrinsic deficits in osteoblast differentiation, we performed in vitro osteoblastogenesis assays with primary cell cultures. We first assayed for bone nodule formation by E13.5 limb primordial cells. PKCd Figure 5O ). These results therefore support the conclusion that PKCd in skeletal progenitor cells promotes osteoblast differentiation.
Lastly, we examined MARCKS phosphorylation levels in the cytosol of E14.5 limb primordial cells. The level of phospho-MARCKS was markedly lower in PKCd À/À cells than in wild-type cells ( Figure 5J ). Thus, MARCKS is likely an endogenous substrate of PKCd in vivo.
Wnt7b Induces Osteoblastogenesis via a Noncanonical, PKCd-Dependent Mechanism
To assess the physiological relevance of Wnt-PKCd signaling in bone formation, we investigated whether Wnt7b, a ligand expressed by osteogenic cells in vivo and able to induce osteoblast differentiation in vitro , signals through this pathway. In keeping with the previous finding, overexpression of Wnt7b, either by transient transfection ( Figure 6F ) or by viral infection ( Figure 6G ), induced AP expression in the multipotent mouse embryonic mesenchymal cell line C3H10T1/2 (Taylor and Jones, 1979) . Moreover, Wnt7b overexpression induced formation of bone nodules in both C3H10T1/2 and ST2 cells in mineralization medium ( Figure 6A ). Finally, Wnt7b also induced osteoblast differentiation in primary cultures of E13.5 limb primordial cells ( Figure 6H ). Interestingly, in the limb cells, Wnt7b induced more robust osteoblastogenesis than a dominant active form of b-catenin (daßcat) ( Figure 6H ), even though >90% cells expressed daßcat, as judged by coexpression of GFP (data not shown). Thus, Wnt7b activates the osteogenic program in multiple cell systems, and activation may include alternative pathways to that mediated by b-catenin. We next examined whether Wnt7b activates the canonical or the PKCd pathway in the cell cultures. Wnt7b failed to activate Lef1-Luciferase expression in either ST2 or C3H10T1/2 cells, even though Wnt3a and daßcat greatly stimulated expression ( Figures 6B and 6C) . Accordingly, Wnt7b failed to stabilize b-catenin in C3H10T1/2 cells ( Figure 6E, top panel) . On the other hand, Wnt7b induced MARCKS phosphorylation in both ST2 ( Figure 6D ) and C3H10T1/2 cells ( Figure 6E ). Thus, Wnt7b does not stimulate canonical Wnt signaling in either ST2 or C3H10T1/2 cells, but it activates PKCd in both cell types.
We then evaluated the potential role of canonical versus PKCd signaling in Wnt7b-induced osteoblastogenesis. Coexpression of Dkk1 did not impair AP induction by Wnt7b in either C3H10T1/2 ( Figure 6G ) or the primary limb primordial cells (data not shown). However, rottlerin strongly inhibited Wnt7b-induced AP activity in both cell types ( Figure 6G and data not shown). Thus, Wnt7b induces osteoblast differentiation in multiple cell systems via the PKCd-mediated noncanonical mechanism.
Genetic Ablation of Wnt7b Results in Deficiency in Embryonic Bone Formation
To assess the physiological role of Wnt7b in bone formation, we genetically removed Wnt7b from the skeletal progenitors by using the Cre-loxP technique. An initial report examining E18.5 embryos devoid of Wnt7b failed to show any clear skeletal phenotype (Rodda and McMahon, 2006) . Here, we generated Wnt7b mutant mice (Dermo1-Cre; Wnt7b n/c3 ) carrying a Wnt7b null allele (Wnt7b n ) (Parr et al., 2001 ), a Wnt7b conditional allele (Wnt7b c3 ;
J.R., T.J.C., and A.P.M., unpublished data), and also a Dermo1-Cre allele (Yu et al., 2003) . The Wnt7b c3 allele had loxP sites flanking the essential exon 3 and functioned as a null allele upon recombination by Cre (to be reported elsewhere). Wnt7b mutant animals were viable after birth and had no obvious phenotype. However, whole-mount skeletal staining revealed that, at E15.5, when wild-type embryos showed obvious ossification, Wnt7b mutant littermates exhibited a diminution in ossification, while some mutant embryos also appeared to be slightly smaller ( Figure 7A) . Regardless of the overall size, the bone collar of long bones was consistently shorter in mutant littermates ( Figure 7B ), as confirmed by quantitation of the relative bone collar length over total length of the element ( Figure 7C ). At E18.5, mutant skulls exhibited less alizarin red staining and widened sutures ( Figure 7D ). Thus, Wnt7b deficiency results in less bone in mouse embryos.
We next examined whether chondrocyte maturation was perturbed in Wnt7b mutants. At E14.5, the overall length of the hypertrophic zone expressing Cola1(X) was similar between mutant and wild-type littermates (Figure 7F) . However, in mutants, the domains expressing PTHrP-R or Ihh were less well separated, and the terminal hypertrophic region expressing MMP13 was clearly reduced. At E15.5, the distance between the two Cola1(X)-expressing domains was significantly reduced in the mutant. Thus, loss of Wnt7b appears to delay subsequent maturation of chondrocytes after the initiation of Cola1(X) expression.
To examine potential intrinsic defects in the osteoblast lineage, we assayed the expression of AP, Bsp, Runx2, Osx, and PTHrP-R in relation to Cola1(X) on adjacent sections of E15.5 long bones. Whereas AP and Runx2 expression in the perichondrium was indistinguishable between mutant and wild-type littermates, the leading edges for Osx, PTHrP-R, and Bsp were consistently closer to the boundary of the hypertrophic zone in the mutant ( Figure 7G) . Thus, removal of Wnt7b, similar to that of PKCd, results in a deficit in Osx activation and subsequent osteoblast differentiation.
To determine whether removal of Wnt7b disrupted canonical Wnt signaling in long bones, we performed in situ hybridization for Dkk1 and Tcf1, two known target genes of the pathway. Both molecules were expressed normally in Wnt7b mutant embryos ( Figure 7I ). In contrast, the limb primordial cells from E14.5 mutant embryos contained a significantly lower level of phospho-MARCKS than wild-type littermates ( Figure 7E ), indicating that Wnt7b stimulates MARCKS phosphorylation in vivo. Thus, the bone defect in Wnt7b mutant embryos is unlikely due to disruption of canonical Wnt signaling, but it appears to correlate with impairment in PKCd activation.
To confirm that Wnt7b directly regulates osteoblast differentiation, we evaluated Wnt7b-deficient cells for their ability to differentiate in vitro. We utilized calvarial cells from neonates, as well as BMSCs from adult mice, both of which contain osteoblast precursors. In both cases, Wnt7b-deficient cells produced significantly fewer bone nodules than wild-type cells ( Figure 7H ). These results are consistent with the notion that endogenous Wnt7b promotes osteoblast differentiation from progenitors.
In summary, to our knowledge, the present study reveals a novel osteogenic pathway in which Wnt molecules, such as Wnt7b, signal through the G q family of G protein a subunits to activate PKCd, which, in turn, promotes the transition from Runx2-to Osx-expressing cells ( Figure 7J ).
DISCUSSION
We have delineated a noncanonical Wnt pathway that operates in mammalian osteoblast precursors to promote bone formation. In this pathway, Wnt activates the G protein-linked phosphatidylinositol signaling and subsequently PKCd, via a mechanism that requires Dvl but is insensitive to Dkk1. Several lines of evidence support that Wnt7b, expressed in osteogenic tissues in vivo, stimulates osteoblast differentiation, likely through the PKCd-mediated pathway. First, genetic ablation of either Wnt7b or PKCd delayed the onset of Osx expression and reduced embryonic bone; second, Wnt7b-or PKCd-deficient osteoprogenitors were defective in osteoblastogenesis in vitro; third, deletion of either gene reduced MARCKS phosphorylation in vivo.
G Proteins and Wnt Signaling
Although the Ga o subunit was recently found to mediate both the Wnt and the planar polarity pathway in Drosophila (Katanaev et al., 2005) , the role of G proteins in Wnt signaling in mammals is not clear. In mouse F9 teratocarcinoma cells, overexpression of chimeric receptors between the b2-adrenergic receptor and rat Frizzled 1 or 2, was reported to activate the canonical Wnt pathway or decrease intracellular cGMP (Ahumada et al., 2002) , respectively, both in a pertussis toxin-sensitive manner. More recently, both Ga o and Ga q were found to mediate Wnt3a-induced stabilization of b-catenin in cell cultures (Liu et al., 2005) . However, the physiological relevance of these findings is not known. Finally, adenylyl cyclase signaling was implicated in Wnt-induced myogenesis , but a direct role of G proteins remains to be confirmed.
The present study indicates that the G q family of a subunits is required for Wnt-induced PKCd activation, but not b-catenin stabilization in osteoprogenitors, and that G q signaling is important for Wnt-induced osteoblast differentiation. These conclusions are supported by studies with a dominant-negative reagent (G q I) and specific siRNA oligonucleotides against Ga q and Ga 11 . Of note, mice missing both alleles of Ga q and one copy of Ga 11 (Ga q À/À ; Ga 11 +/À ) developed to term, but exhibited severe bone defects in the craniofacial skeleton (Offermanns et al., 1998) . In addition, in Xenopus embryos, G q , but not G i , signaling mediated XWnt8a-induced axis duplication as well as mesoderm ventralization (Wu et al., 2000) , although it was not clear whether in that system G q signaled through b-catenin or an alternative pathway. Finally, it may be of interest to examine whether similar G protein signaling mediates cardiomyocyte differentiation induced by Wnt11, previously reported to be independent of b-catenin signaling (Koyanagi et al., 2005; Pandur et al., 2002) .
Canonical versus Noncanonical Wnt Signaling
The mechanism for activating canonical versus noncanonical pathways by Wnt molecules is not clear. Wnt3a signaled through both the b-catenin and the PKCd pathway in ST2 cells, whereas Wnt7b selectively activated the later in multiple cell types. The two pathways differed not only in their dependence on the LRP5/6 coreceptor, but also in their requirement for G q signaling. This could indicate that Wnt3a induces the formation of two distinct signaling complexes or a single complex with dual signaling properties. The specificity of signaling complexes may be dictated by the Frizzled receptor(s), as forced expression of mouse Frizzled 4 in HEK293 cells (Mikels and Nusse, 2006) or human Frizzled 5 in Xenopus embryos (He et al., 1997) was sufficient to transduce canonical signaling by Wnt5a, which was otherwise inactive in this regard. Moreover, overexpression of different mouse Frizzled molecules in the Xenopus embryo was found to activate either classic PKC or downstream target genes of b-catenin (Sheldahl et al., 1999) . Finally, Wnts may signal through receptors other than Frizzleds, such as the atypical receptor kinase Ryk (Lu et al., 2004; Schmitt et al., 2006) or the orphan receptor tyrosine kinase Ror2 (Mikels and Nusse, 2006 Developmental Cell roles of other Wnts or PKC isoforms important for osteoblastogenesis. Alternatively, Wnt-PKCd signaling could represent a mechanism that augments other osteogenic signals, but itself is not essential for osteoblast differentiation in vivo. In this scenario, the noncanonical pathway appears to perform a function distinct from that of canonical Wnt signaling, as thus far inferred from genetic studies of b-catenin (Day et al., 2005; Hill et al., 2005; Hu et al., 2005; Rodda and McMahon, 2006) .
The mechanism for Wnt7b and PKCd to regulate the onset of Osx expression is presently unknown. Although an immediate target of Wnt-PKCd signaling, MARCKS has not been implicated in bone formation. The MARCKS À/À mice had severe defects in neural development and exhibited perinatal lethality (Stumpo et al., 1995) , but analyses of the skeletons of these mutant embryos have so far not revealed any obvious defects (data not shown). It is possible that other PKCd substrates mediate osteoblast differentiation.
Frizzled-G Protein Signaling as a Target for Bone Anabolic Therapeutics
The present study identified a novel, to our knowledge, mechanism for Wnt signals to stimulate bone formation. Importantly, this pathway can be uncoupled from canonical Wnt signaling and is mediated through specific G proteins that are likely coupled with the Frizzled receptors. Thus, reagents that selectively activate G protein signaling by the relevant receptors may provide specific bone anabolic effects.
EXPERIMENTAL PROCEDURES
Plasmids and Oligonucleotides
Full-length Wnt7b cDNA was purchased from ATCC. The Lef1-luciferase reporter (Mao et al., 2001b) and the cDNAs for the dominant active form of b-catenin (Tetsu and McCormick, 1999) , GqI (Akhter et al., 1998) , and Dvl-2 derivatives (Habas et al., 2001 ) were as previously described. The full-length cDNA for PKCd was cloned by PCR from a mouse E15 Marathon-Ready cDNA pool (BD Biosciences Clontech), and the cDNA for the truncated form (PKCd-DC, aa 1-338) was generated by a second PCR from the full-length cDNA. The siRNA oligonucleotides for PKCd were purchased from Dharmacon, and those for Ga q and Ga 11 were purchased from Ambion.
Antibodies, Proteins, and Chemicals
The polyclonal antibodies against PKCd and MARCKS; the monoclonal antibodies against a-tubulin, Dvl-1, Dvl-2, and Dvl-3; and the HRP-conjugated secondary antibodies were purchased from Santa Cruz Biotechnology. The monoclonal antibodies against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and b-catenin were purchased from Chemicon and BD Biosciences Pharmigen, respectively. The polyclonal antibody against phospho-MARCKS was purchased from Cell Signaling. The polyclonal antibody against Ga q and Ga 11 was purchased from Calbiochem. The Alexa 488-or 555-conjugated secondary antibodies were purchased from Molecular Probes. Purified recombinant Wnt3a was purchased from R&D systems. All inhibitors for PKC and PLC were purchased from Calbiochem.
Cell Cultures C3H10T1/2 cells, Wnt3a-expressing cells, and control L cells were obtained from ATCC and were maintained in BME with 10% bovine serum (Atlas) as per instructions. ST2 cells (Dr. Steve Teitelbaum, Washington University) were maintained in a-MEM (Sigma). Unless otherwise indicated, ST2 cells were seeded at 1.5 3 10 4 cells/cm 2 overnight before experiments. Wnt3a-and L-conditioned medium were used at 1:2 dilution in normal growth medium. The Ultraculture serum-free medium was purchased from Cambrex. Primary cultures of limb primordial cells were dissociated from the stylopod and zeugopod region of the forelimb of E13.5 mouse embryos; primary cultures of the calvarial cells were isolated from 2-day-old newborn mice. Cells were seeded at 1 3 10 5 cells/cm 2 in a-MEM with 10% bovine serum and were used without passage. Primary cultures of the bone marrow stromal cells (BMSCs) were isolated from the femur and the tibia of 5-week-old mice and were plated in a-MEM with 15% bovine serum; medium was changed at day 3 and day 6. Cells were passed once at days 7-8 and were reseeded at 1 3 10 5 cells/cm 2 for AP or mineralization assays.
Infections and Transfections
Viruses expressing GFP or Dkk1 were as previously described . Viruses expressing Wnt7b, PKCd, PKCd-DC, G q I, or the Dvl-2 derivatives were generated in the same manner, and all coexpressed nuclear GFP via an internal ribosome entry site (IRES). A proper dilution of each virus stock in appropriate growth medium was chosen to achieve >90% infection as per GFP detection. For infections, cells were incubated at about 50% confluency in virus-containing medium for 24 hr. Transient transfections were performed with Lipofectamine (Invitrogen) and, in some cases, after cells were infected with viruses. Luciferase and AP assays were performed at 48 hr after transfection.
Transfections of siRNA oligonucleotides were performed with si-PORT Amine (Ambion). Four distinct siRNA duplexes each for Ga q and Ga 11 were individually tested; two in each case were found to be effective and were used in experiments reported here. For PKCd, a pool of four siRNA duplexes was used.
Osteoblast Differentiation Assays AP expression was detected as previously described (Katagiri et al., 1994) . When inhibitors were used, cells were pretreated with the inhibitor in normal growth medium for 1 hr. For mineralization assays, confluent cells were incubated in the presence of 50 mg/ml ascorbic acid and 50 mM b-glycerophosphate for 14-21 days. Real-time PCR for osteoblast markers was performed as previously described .
Proteomics, Western Analyses, and Immunocytochemistry For proteomics, ST2 cells were cultured in Wnt3a or L medium for 24 hr before total cell lysates were harvested by using a lysis buffer containing a protease inhibitor cocktail (Roche) and phosphatase inhibitor cocktail 1 and 2 (Sigma). Proteomic analyses were performed at the Siteman Cancer Center Proteomics Core Facility (Washington University).
Western analyses were performed by using the ECL Plus Western Blotting Detection System (Amersham Biosciences). The intensity of protein bands was quantified with ImageJ (http://rsb.info.nih.gov/ij/). For analyses of mutant embryos, E14.5 limbs were skinned, homogenized, and extracted for cytosolic proteins in the presence of protease and phosphatase inhibitors.
Immunocytochemistry was performed on chamber slides (Nalge Nunc International). Cells seeded at 0.75 3 10 4 /cm 2 were cultured overnight in regular medium, and then either directly switched to serum-free medium for 24 hr or first infected with retroviruses before changing to serum-free medium. Cells were then stimulated in fresh serum-free medium for 30 min with recombinant Wnt3a protein at 50 ng/ml, and cells were finally immunostained and examined by confocal microscopy.
Mouse Strains and Analyses
The PKCd +/À (Miyamoto et al., 2002) , the Dermo1-Cre (Yu et al., 2003) , and the Wnt7b +/À (Parr et al., 2001 ) mouse strains were previously described. Whole-mount skeletal staining, mouse embryo tissue processing, von Kossa staining, and in situ hybridization were performed as described . To quantitate relative bone length, multiple sections representing different sectioning planes were stained by von Kossa, and ratios of bone collar length over total length of the element were calculated. 
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